A Clinical Practice Guideline Summary for Pharmacological Management of Adults with Major Depressive Disorder in Malaysia

被引:0
|
作者
Abousheishaa, Aya Ahmed [1 ]
Sue-Yin, Low [2 ]
Khin, Kok Chee [3 ]
Sulaiman, Ahmad Hatim [1 ]
Huri, Hasniza Zaman [4 ]
Guan, Ng Chong [1 ]
机构
[1] Univ Malaya, Dept Psychol Med, Fac Med, Kuala Lumpur, Malaysia
[2] HELP Univ, Fac Behav Sci, Dept Psychol, Kuala Lumpur, Malaysia
[3] Univ Malaya, Dept Pharm, Med Ctr, Kuala Lumpur, Malaysia
[4] Univ Malaya, Fac Pharm, Kuala Lumpur, Malaysia
关键词
Major depressive disorder; clinical practice guidelines; evidence-based practice; RECOMMENDATIONS; ADAPTATION; ADHERENCE; MOOD;
D O I
10.9734/JPRI/2021/v33i45B32821
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Clinical Practice Guidelines (CPGs) are systematically developed statements to assist practitioners and patients with appropriate health care for specific clinical circumstances. However, evidence suggests that the uptake of these recommendations in routine care is still limited, particularly in resource-constrained countries. Objectives: This article aimed to (1) identify current CPGs for the pharmacological management of MDD that address and are compatible with the needs of Malaysian psychiatrists (2) collate and summarise these CPG recommendations to produce a more culturally sensitive and end-user friendly guideline summary. Materials and Methods: A multidisciplinary steering group followed an adapted development approach that included; (1) searching for guidelines on the pharmacological management of adults with depression, (2) screening them for relevant recommendations, (3) critical appraising these guidelines, and (4) extracting the required information. A panel of experts then reviewed the developed guideline summary. Results: Six potentially relevant guidelines for the pharmacological management of depression in adults were identified. The developed summary included a decision algorithm to guide the selection of antidepressant therapy based on clinical factors, potential drug-drug interaction, tolerability, and cost of the medications. The review panel considered the summary recommendations easy to use and had the potential for uptake by busy psychiatrists. Conclusion: A CPG summary for the pharmacological management of depression was developed that focuses on evidence-based, contextually relevant recommendations that are feasible for implementation within the local healthcare settings in Malaysia. Practical Implications: The developed guideline summary has the potential to enhance the implementation of evidence-based practice in the management of Major Depressive Disorder within the Malaysian context.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 50 条
  • [31] Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults
    MacQueen, Glenda
    Santaguida, Pasqualina
    Keshavarz, Homa
    Jaworska, Natalia
    Levine, Mitchell
    Beyene, Joseph
    Raina, Parminder
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2017, 62 (01): : 11 - 23
  • [32] A Primary Care Focus on the Diagnosis and Treatment of Major Depressive Disorder in Adults
    Halaris, Angelos
    JOURNAL OF PSYCHIATRIC PRACTICE, 2011, 17 (05) : 340 - 350
  • [33] A retrospective analysis of vortioxetine utilization in children and adolescents with major depressive disorder in clinical practice
    Xianmei Luo
    Shu Yu
    Keliang Pan
    Lin Cheng
    Fan Luo
    Handi Zhang
    Mingjun Duan
    Yajun Zhang
    BMC Psychiatry, 25 (1)
  • [34] Spotlight on Escitalopram in the Management of Major Depressive Disorder
    David Murdoch
    Susan J. Keam
    CNS Drugs, 2006, 20 : 167 - 170
  • [35] Transcranial direct current stimulation for the treatment of major depressive disorder: A summary of preclinical, clinical and translational findings
    Brunoni, Andre Russowsky
    Ferrucci, Roberta
    Fregni, Felipe
    Boggio, Paulo Sergio
    Priori, Alberto
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 39 (01) : 9 - 16
  • [36] Reduced immunity to measles in adults with major depressive disorder
    Ford, Bart N.
    Yolken, Robert H.
    Dickerson, Faith B.
    Teague, T. Kent
    Irwin, Michael R.
    Paulus, Martin P.
    Savitz, Jonathan
    PSYCHOLOGICAL MEDICINE, 2019, 49 (02) : 243 - 249
  • [37] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments
    Milev, Roumen V.
    Giacobbe, Peter
    Kennedy, Sidney H.
    Blumberger, Daniel M.
    Daskalakis, Zafiris J.
    Downar, Jonathan
    Modirrousta, Mandana
    Patry, Simon
    Vila-Rodriguez, Fidel
    Lam, Raymond W.
    MacQueen, Glenda M.
    Parikh, Sagar V.
    Ravindran, Arun V.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2016, 61 (09): : 561 - 575
  • [38] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments
    Parikh, Sagar V.
    Quilty, Lena C.
    Ravitz, Paula
    Rosenbluth, Michael
    Pavlova, Barbara
    Grigoriadis, Sophie
    Velyvis, Vytas
    Kennedy, Sidney H.
    Lam, Raymond W.
    MacQueen, Glenda M.
    Milev, Roumen V.
    Ravindran, Arun V.
    Uher, Rudolf
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2016, 61 (09): : 524 - 539
  • [39] Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use
    Singh, Mandeep
    Schwartz, Thomas L.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 123 - 130
  • [40] Ruminative response in clinical patients with major depressive disorder, bipolar disorder, and anxiety disorders
    Kim, Sojung
    Yu, Bum Hee
    Lee, Dong Soo
    Kim, Ji-Hae
    JOURNAL OF AFFECTIVE DISORDERS, 2012, 136 (1-2) : E77 - E81